Cox-MAZE IV with Coronary Artery Bypass Graft (CABG) and Mitral Valve Replacement (MVR)
Andrew Del Re1; Marco Zenati, MD2
1 The Warren Alpert Medical School of Brown University
2 Brigham & Women’s Hospital, VA Boston Healthcare System
Cardiovascular disease is a leading cause of morbidity and mortality in the United States and abroad, manifesting as shortness of breath, exercise intolerance, palpitations, and chest pain. While the majority of cases are treated medically, more advanced or severe cases are treated surgically or endovascularly, warranting an open discussion between the provider and the patient to decide the most appropriate treatment modality given the specific characteristics and preferences of the procedure and the patient.
The Cox-MAZE IV combined with CABG and Mitral Valve Replacement is a singular surgical procedure that is carefully planned and executed to address arrhythmic, coronary, and valvular disease while minimizing time on cardiopulmonary bypass with an arrested heart.